Amgen (AMGN)
(Delayed Data from NSDQ)
$324.69 USD
+12.19 (3.90%)
Updated Aug 8, 2024 04:00 PM ET
After-Market: $325.15 +0.46 (0.14%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth D Momentum D VGM
Brokerage Reports
Amgen Inc. [AMGN]
Reports for Purchase
Showing records 301 - 320 ( 434 total )
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Repatha Outcomes Met Key Endpoints but Missed Mortality - Hold
Provider: G.RESEARCH, LLC
Analyst: HE J